Literature DB >> 21711127

Epithelial-mesenchymal transition contributes to SWCNT-induced pulmonary fibrosis.

Chih-Ching Chang1, Mei-Ling Tsai, Hui-Chun Huang, Chin-Yu Chen, Shi-Xun Dai.   

Abstract

Previous studies suggest that single-walled carbon nanotube (SWCNT) exposure causes pulmonary fibrosis. We investigated the contribution of epithelial-mesenchymal transition (EMT) during SWCNT-induced pulmonary fibrosis. C57BL6 female mice were intratracheally instilled with SWCNT at 80 μg/mouse for up to 56 days. SWCNT exposure caused pulmonary epithelial and mesenchymal injury, followed by granulomatous and fibrotic changes. Immunofluorescence staining demonstrated the increasing occurrence of epithelial-derived fibroblasts up to 42 days post-exposure. Flow cytometry analysis revealed that 42.60% of N-cadherin (N-cad)-positive fibroblasts were derived from pulmonary epithelial cells, and, in separate experiments, 30.68% of SPC positive cells were stained for N-cad at 42 days. These epithelial-derived fibroblasts were functional in collagen production. With the progression of fibrosis, there were increases in the number of hyperplastic epithelial cells stained positively for TGF-β/p-Smad2 or β-catenin. Therefore, EMT contributes significantly to fibroblast expansion. Aberrant activations of TGF-β/p-Smad2 and β-catenin are postulated to induce EMT during SWCNT-induced pathogenic fibrosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21711127     DOI: 10.3109/17435390.2011.594913

Source DB:  PubMed          Journal:  Nanotoxicology        ISSN: 1743-5390            Impact factor:   5.913


  18 in total

Review 1.  Epithelial-mesenchymal transition: An emerging target in tissue fibrosis.

Authors:  Meirong Li; Fuxin Luan; Yali Zhao; Haojie Hao; Yong Zhou; Weidong Han; Xiaobing Fu
Journal:  Exp Biol Med (Maywood)       Date:  2015-09-11

2.  Identification of TGF-β receptor-1 as a key regulator of carbon nanotube-induced fibrogenesis.

Authors:  Anurag Mishra; Todd A Stueckle; Robert R Mercer; Raymond Derk; Yon Rojanasakul; Vincent Castranova; Liying Wang
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-08-21       Impact factor: 5.464

Review 3.  Integration of inflammation, fibrosis, and cancer induced by carbon nanotubes.

Authors:  Jie Dong; Qiang Ma
Journal:  Nanotoxicology       Date:  2019-09-19       Impact factor: 5.913

Review 4.  The role of the epithelial-to-mesenchymal transition (EMT) in diseases of the salivary glands.

Authors:  Margherita Sisto; Sabrina Lisi; Domenico Ribatti
Journal:  Histochem Cell Biol       Date:  2018-05-23       Impact factor: 4.304

Review 5.  Advances in mechanisms and signaling pathways of carbon nanotube toxicity.

Authors:  Jie Dong; Qiang Ma
Journal:  Nanotoxicology       Date:  2015-02-13       Impact factor: 5.913

6.  Effects of lipopolysaccharide, multiwalled carbon nantoubes, and the combination on lung alveolar epithelial cells.

Authors:  M Pacurari; I May; P B Tchounwou
Journal:  Environ Toxicol       Date:  2016-02-16       Impact factor: 4.119

Review 7.  Mechanisms of carbon nanotube-induced pulmonary fibrosis: a physicochemical characteristic perspective.

Authors:  Katherine S Duke; James C Bonner
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2017-10-06

Review 8.  Pulmonary toxicity and fibrogenic response of carbon nanotubes.

Authors:  Amruta Manke; Liying Wang; Yon Rojanasakul
Journal:  Toxicol Mech Methods       Date:  2013-01-16       Impact factor: 2.987

9.  Doxycycline attenuates paraquat-induced pulmonary fibrosis by downregulating the TGF-β signaling pathway.

Authors:  Xu-Fang Hua; Xiao-He Li; Mi-Mi Li; Cheng-Yu Zhang; Hui-Juan Liu; Tao Sun; Hong-Gang Zhou; Cheng Yang
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

10.  MMP-3 activation is involved in copper oxide nanoparticle-induced epithelial-mesenchymal transition in human lung epithelial cells.

Authors:  Yuanbao Zhang; Yiqun Mo; Jiali Yuan; Yue Zhang; Luke Mo; Qunwei Zhang
Journal:  Nanotoxicology       Date:  2022-02-02       Impact factor: 5.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.